- Home
- LVLU vs IXHL Comparison
LVLU vs IXHL Comparison
Compare LVLU & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- IXHL
- Stock Information
- Founded
- LVLU 1996
- IXHL 2001
- Country
- LVLU United States
- IXHL Australia
- Employees
- LVLU N/A
- IXHL N/A
- Industry
- LVLU Catalog/Specialty Distribution
- IXHL
- Sector
- LVLU Consumer Discretionary
- IXHL
- Exchange
- LVLU Nasdaq
- IXHL Nasdaq
- Market Cap
- LVLU 18.4M
- IXHL 20.2M
- IPO Year
- LVLU 2021
- IXHL N/A
- Fundamental
- Price
- LVLU $4.66
- IXHL $0.21
- Analyst Decision
- LVLU Hold
- IXHL
- Analyst Count
- LVLU 2
- IXHL 0
- Target Price
- LVLU $1.00
- IXHL N/A
- AVG Volume (30 Days)
- LVLU 782.4K
- IXHL 38.8M
- Earning Date
- LVLU 08-13-2025
- IXHL 05-15-2025
- Dividend Yield
- LVLU N/A
- IXHL N/A
- EPS Growth
- LVLU N/A
- IXHL N/A
- EPS
- LVLU N/A
- IXHL N/A
- Revenue
- LVLU $302,783,000.00
- IXHL $98,000.00
- Revenue This Year
- LVLU N/A
- IXHL $3,817.06
- Revenue Next Year
- LVLU $2.53
- IXHL $66.67
- P/E Ratio
- LVLU N/A
- IXHL N/A
- Revenue Growth
- LVLU N/A
- IXHL N/A
- 52 Week Low
- LVLU $0.22
- IXHL $0.08
- 52 Week High
- LVLU $5.25
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- LVLU 41.76
- IXHL 46.96
- Support Level
- LVLU $3.30
- IXHL $0.20
- Resistance Level
- LVLU $5.43
- IXHL $0.23
- Average True Range (ATR)
- LVLU 1.44
- IXHL 0.01
- MACD
- LVLU -0.13
- IXHL 0.00
- Stochastic Oscillator
- LVLU 26.59
- IXHL 30.73
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.